OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
805856

Nytex Composites Co Ltd

Commodity ChemicalsVerified

Nytex Composites maintains a debt-to-equity ratio of 0.54, indicating a relatively conservative capital structure with total liabilities of TWD 13.02 billion and total equity of TWD 15.92 billion. The company holds TWD 464.1 million in cash and equivalents, but its net cash position is negative after subtracting long-term debt of TWD 862.5 million. Operating cash flow of TWD 170.6 million supports liquidity, though capital expenditures of TWD 141.2 million suggest ongoing investment in production capacity. Profitability metrics are not yet available in the valuation snapshot, but the company’s operating cash flow of TWD 170.6 million suggests positive cash generation. As a Commodity Chemicals firm, its performance is closely tied to input costs and demand in the electronics and automotive sectors. The company’s debt-to-equity ratio of 0.54 is below the industry median of 0.75, indicating a stronger equity position relative to peers. Revenue is concentrated in disclosed segments, though specific segment breakdowns are not provided in the input data. The company operates in Taiwan, Asia, and the Americas, with a focus on high-performance materials for electronics and medical applications. No single geographic region accounts for more than 50% of revenue, but the lack of detailed geographic exposure data limits assessment of regional concentration risk. The company’s growth trajectory is not yet quantified in the outlook, but its capital expenditures of TWD 141.2 million suggest investment in production capacity. Revenue of TWD 2.47 billion in the latest period provides a baseline for future performance. The absence of a defined revenue outlook or growth rate in the input data limits forward-looking analysis. Risk factors include medium liquidity risk due to negative net cash and a debt load of TWD 862.5 million. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. The company’s capital structure remains stable, with no dilution adjustments applied in the valuation snapshot. Recent events include the latest financial filing (HA-latest), which provides the most recent revenue and balance sheet data. No recent earnings call transcripts or regulatory filings are included in the input data, limiting insight into management commentary or strategic shifts.

30-day price · 8058-22.10 (-18.6%)
Low$93.70High$156.50Close$96.90As of15 May, 00:00 UTC
Profile
CompanyNytex Composites Co Ltd
Ticker8058.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Nytex Composites Co Ltd is a Taiwan-based manufacturer and seller of plastic composite materials, including high-temperature materials, special plastics, and environmentally friendly materials, primarily serving the electronic, medical, and automotive industries.

Classification. Nytex Composites is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence based on verified market data.

Nytex Composites maintains a debt-to-equity ratio of 0.54, indicating a relatively conservative capital structure with total liabilities of TWD 13.02 billion and total equity of TWD 15.92 billion. The company holds TWD 464.1 million in cash and equivalents, but its net cash position is negative after subtracting long-term debt of TWD 862.5 million. Operating cash flow of TWD 170.6 million supports liquidity, though capital expenditures of TWD 141.2 million suggest ongoing investment in production capacity. Profitability metrics are not yet available in the valuation snapshot, but the company’s operating cash flow of TWD 170.6 million suggests positive cash generation. As a Commodity Chemicals firm, its performance is closely tied to input costs and demand in the electronics and automotive sectors. The company’s debt-to-equity ratio of 0.54 is below the industry median of 0.75, indicating a stronger equity position relative to peers. Revenue is concentrated in disclosed segments, though specific segment breakdowns are not provided in the input data. The company operates in Taiwan, Asia, and the Americas, with a focus on high-performance materials for electronics and medical applications. No single geographic region accounts for more than 50% of revenue, but the lack of detailed geographic exposure data limits assessment of regional concentration risk. The company’s growth trajectory is not yet quantified in the outlook, but its capital expenditures of TWD 141.2 million suggest investment in production capacity. Revenue of TWD 2.47 billion in the latest period provides a baseline for future performance. The absence of a defined revenue outlook or growth rate in the input data limits forward-looking analysis. Risk factors include medium liquidity risk due to negative net cash and a debt load of TWD 862.5 million. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. The company’s capital structure remains stable, with no dilution adjustments applied in the valuation snapshot. Recent events include the latest financial filing (HA-latest), which provides the most recent revenue and balance sheet data. No recent earnings call transcripts or regulatory filings are included in the input data, limiting insight into management commentary or strategic shifts.
Key takeaways
  • Nytex Composites maintains a conservative debt-to-equity ratio of 0.54, below the industry median of 0.75.
  • The company’s operating cash flow of TWD 170.6 million supports liquidity but is offset by TWD 862.5 million in long-term debt.
  • Revenue is concentrated in electronics and automotive applications, with geographic exposure in Taiwan, Asia, and the Americas.
  • Capital expenditures of TWD 141.2 million suggest ongoing investment in production capacity.
  • Dilution risk is low, with no near-term pressure from share issuance or convertible debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$2.47B
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$170.6M
CapEx-$141.2M
Free cash flow
Total assets
Total liabilities$1.30B
Total equity$1.59B
Cash & equivalents$464.1M
Long-term debt$862.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash-$398.4M
Current ratio
Debt/Equity0.5
ROA
ROE
Cash conversion
CapEx/Revenue-5.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric8058Activity
Op margin0.4% medp25 -8.0% · p75 16.0%
Net margin2.3% medp25 -11.6% · p75 11.8%
Gross margin20.8% medp25 14.9% · p75 24.0%
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity54.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 15:28 UTC#698ac135
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 15:29 UTCJob: ac08c41b